Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Tenax Therapeutics stock

Learn how to easily invest in Tenax Therapeutics stock.

Tenax Therapeutics Inc is a biotechnology business based in the US. Tenax Therapeutics shares (TENX) are listed on the NASDAQ and all prices are listed in US Dollars. Tenax Therapeutics employs 8 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Tenax Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TENX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Tenax Therapeutics stock price (NASDAQ: TENX)

Use our graph to track the performance of TENX stocks over time.

Tenax Therapeutics shares at a glance

Information last updated 2022-06-25.
Latest market close$0.32
52-week range$0.23 - $2.27
50-day moving average $0.63
200-day moving average $0.97
Wall St. target price$4.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.49

Buy Tenax Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tenax Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tenax Therapeutics price performance over time

Historical closes compared with the close of $0.3182 from 2022-07-01

1 week (2022-06-24) 2.51%
1 month (2022-06-01) -51.79%
3 months (2022-04-01) -59.11%
6 months (2021-12-31) -69.40%
1 year (2021-07-02) -83.85%
2 years (2020-07-02) -64.75%
3 years (2019-07-02) 1.35
5 years (2017-06-30) 0.7391

Tenax Therapeutics financials

Gross profit TTM $0
Return on assets TTM -158.13%
Return on equity TTM -486.94%
Profit margin 0%
Book value $0.06
Market capitalisation $7.8 million

TTM: trailing 12 months

Tenax Therapeutics share dividends

We're not expecting Tenax Therapeutics to pay a dividend over the next 12 months.

Have Tenax Therapeutics's shares ever split?

Tenax Therapeutics's shares were split on a 1:20 basis on 25 February 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tenax Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Tenax Therapeutics shares which in turn could have impacted Tenax Therapeutics's share price.

Tenax Therapeutics share price volatility

Over the last 12 months, Tenax Therapeutics's shares have ranged in value from as little as $0.234 up to $2.266. A popular way to gauge a stock's volatility is its "beta".

TENX.US volatility(beta: 2.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tenax Therapeutics's is 2.0113. This would suggest that Tenax Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Tenax Therapeutics overview

Tenax Therapeutics, Inc. , a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc.

Frequently asked questions

What percentage of Tenax Therapeutics is owned by insiders or institutions?
Currently 36.222% of Tenax Therapeutics shares are held by insiders and 32.073% by institutions.
How many people work for Tenax Therapeutics?
Latest data suggests 8 work at Tenax Therapeutics.
When does the fiscal year end for Tenax Therapeutics?
Tenax Therapeutics's fiscal year ends in December.
Where is Tenax Therapeutics based?
Tenax Therapeutics's address is: ONE Copley Parkway, Morrisville, NC, United States, 27560
What is Tenax Therapeutics's ISIN number?
Tenax Therapeutics's international securities identification number is: US88032L2097
What is Tenax Therapeutics's CUSIP number?
Tenax Therapeutics's Committee on Uniform Securities Identification Procedures number is: 69207P100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site